Amedeo Smart

Free Medical Literature Service

 

Amedeo

Biliary Tract Diseases
  Free Subscription

Articles published in
Eur J Gastroenterol Hepatol
    July 2026
  1. LI B, Li S, Chen S, Li M, et al
    Fenofibrate add-on therapy improves transplant-free survival in primary biliary cholangitis patients.
    Eur J Gastroenterol Hepatol. 2026;38:851-859.
    >> Share

    June 2026
  2. SACCO M, Mediati F, Palmieri P, Caronna S, et al
    Age-related outcomes of digital single-operator cholangio-pancreatoscopy: a single-center retrospective study.
    Eur J Gastroenterol Hepatol. 2026 Jun 3. doi: 10.1097/MEG.0000000000003230.
    >> Share

    May 2026
  3. LI B, Li S, Chen S, Li M, et al
    Fenofibrate add-on therapy improves transplant-free survival in primary biliary cholangitis patients.
    Eur J Gastroenterol Hepatol. 2026 May 8. doi: 10.1097/MEG.0000000000003154.
    >> Share

    April 2026
  4. OU S, Xu C, Chen Z, Li Z, et al
    Usefulness of the clip-with-line method for difficult biliary cannulation in Billroth II gastrectomy.
    Eur J Gastroenterol Hepatol. 2026;38:517-520.
    >> Share

    March 2026
  5. KHOURY T, Benson AA, Goldsztein M, Mubariki N, et al
    Fully covered metal stents as a risk factor for acute cholecystitis in patients with biliary stricture: a multicenter retrospective study.
    Eur J Gastroenterol Hepatol. 2026 Mar 30. doi: 10.1097/MEG.0000000000003192.
    >> Share

  6. COMOGLU E, Acehan F, Altiparmak E, Ates I, et al
    Early identification of the need for biliary drainage in acute calculous cholangitis: a prospective cohort study.
    Eur J Gastroenterol Hepatol. 2026 Mar 30. doi: 10.1097/MEG.0000000000003189.
    >> Share

  7. MEMON GM
    Endoscopic retrograde cholangiopancreatography discharge tool combined with rapid trypsinogen-2 test to predict same-day discharge: a prospective cohort study.
    Eur J Gastroenterol Hepatol. 2026;38:391.
    >> Share

  8. PARAKKAD AN
    Assessing ChatGPT's role in patient education on cholangiocarcinoma: promise, pitfalls, and a call for validation.
    Eur J Gastroenterol Hepatol. 2026;38:386-387.
    >> Share

  9. SILVEIRA IB, Moraes BF, Rezende RAA, Cancado GGL, et al
    Reconciling the role of ileal bile acid transporter inhibitors as symptom-directed therapy in primary biliary cholangitis: a focused meta-analysis.
    Eur J Gastroenterol Hepatol. 2026;38:384-385.
    >> Share

    February 2026
  10. SLEUTJES JAM, van de Pol N, van der Meer AJ, de Man RA, et al
    Cardiovascular risk profiles in patients with primary sclerosing cholangitis.
    Eur J Gastroenterol Hepatol. 2026 Feb 23. doi: 10.1097/MEG.0000000000003146.
    >> Share

  11. SAH SS, Kumbhalwar A
    Comment on 'endoscopic retrograde cholangiopancreatography discharge tool combined with rapid trypsinogen-2 test to predict same-day discharge: a prospective cohort study'.
    Eur J Gastroenterol Hepatol. 2026;38:234.
    >> Share

    January 2026
  12. BIAN L, Luo L, Kang G, Liu Y, et al
    Safety evaluation of drug-eluting bead transarterial chemoembolization in combination with immune checkpoint inhibitors in the treatment of unresectable intrahepatic cholangiocarcinoma: risk factors for liver abscess.
    Eur J Gastroenterol Hepatol. 2026 Jan 15. doi: 10.1097/MEG.0000000000003141.
    >> Share

    December 2025
  13. TANG L, Mo J, Ouyang J, Li W, et al
    A multilevel analysis of the genetic association between inflammatory bowel disease and primary sclerosing cholangitis.
    Eur J Gastroenterol Hepatol. 2025 Dec 9. doi: 10.1097/MEG.0000000000003116.
    >> Share

    September 2025
  14. KOKER G
    Malignant bile duct obstruction and the microbiota: encouraging advances and unanswered questions.
    Eur J Gastroenterol Hepatol. 2025;37:1091.
    >> Share

    July 2025
  15. CUI Y, Li J, Huang Q, Hong J, et al
    Accuracy of the American Society for Gastrointestinal Endoscopy, European Society of Gastrointestinal Endoscopy, and Society of American Gastrointestinal and Endoscopic Surgeons criteria in predicting common bile duct microlithiasis.
    Eur J Gastroenterol Hepatol. 2025 Jul 18. doi: 10.1097/MEG.0000000000003037.
    >> Share

    June 2025
  16. SPERNA WEILAND CJ, Engels MML, Scheffer RCH, Van Balkom B, et al
    Endoscopic retrograde cholangiopancreatography discharge tool combined with rapid trypsinogen-2 test to predict same-day discharge: a prospective cohort study.
    Eur J Gastroenterol Hepatol. 2025 Jun 18. doi: 10.1097/MEG.0000000000003014.
    >> Share

    May 2025
  17. QIAN L, Wang L, Zou Z, Luan F, et al
    Distinct composition and metabolic potential of biliary microbiota in patients with malignant bile duct obstruction.
    Eur J Gastroenterol Hepatol. 2025;37:585-593.
    >> Share

    March 2025
  18. HU Y, Liu M, Li S, Ji Y, et al
    Co-occurrence of autoimmune liver disease and gallstones: a clinically overlooked phenomenon.
    Eur J Gastroenterol Hepatol. 2025 Mar 26. doi: 10.1097/MEG.0000000000002978.
    >> Share

  19. SAEED A, Yousuf S, Khan MA, Gangwani MK, et al
    Biliary stenting with and without endoscopic sphincterotomy in patients with malignant biliary obstruction: meta-analysis of randomized controlled trials.
    Eur J Gastroenterol Hepatol. 2025;37:257-262.
    >> Share

    February 2025
  20. ZHAO Z, Wu H, Han J, Jiang K, et al
    Global trends and disparities in gallbladder and biliary tract cancers: insights from the global burden of disease study 2021.
    Eur J Gastroenterol Hepatol. 2025 Feb 14. doi: 10.1097/MEG.0000000000002947.
    >> Share

    December 2024
  21. MOHAMED I, Naeem A, Hassan N, Jung D, et al
    Comparative efficacy and safety of SpyGlass percutaneous transhepatic cholangioscopy versus conventional cholangioscopy in challenging biliary access: a systematic review and meta-analysis.
    Eur J Gastroenterol Hepatol. 2024 Dec 17. doi: 10.1097/MEG.0000000000002909.
    >> Share

  22. CHEN Q, Kong D, Liu X
    Secondary sclerosing cholangitis due to drug-induced liver injury: a retrospective cohort study.
    Eur J Gastroenterol Hepatol. 2024 Dec 2. doi: 10.1097/MEG.0000000000002902.
    >> Share

  23. ZHANG R, Tan Y, Liu M, Wang L, et al
    Lymph node metastasis of intrahepatic cholangiocarcinoma: the present and prospect of detection and dissection.
    Eur J Gastroenterol Hepatol. 2024;36:1359-1369.
    >> Share

    November 2024
  24. ZHANG S, Zhou T, Wu M, Xiong X, et al
    Sarcopenia is associated with new-onset acute biliary infection within 1 year in patients with hepatitis B virus-related decompensated cirrhosis.
    Eur J Gastroenterol Hepatol. 2024 Nov 8. doi: 10.1097/MEG.0000000000002875.
    >> Share

    September 2024
  25. ZHAO J, Wang B, Zhao M, Pan X, et al
    Clinical and biochemical factors for bacteria in bile among patients with acute cholangitis.
    Eur J Gastroenterol Hepatol. 2024 Sep 11. doi: 10.1097/MEG.0000000000002849.
    >> Share

    July 2024
  26. ZHOU X, Xu L, Zhang Q, Chen W, et al
    The impact of long-term (>/=5 years) cholecystectomy on gut microbiota changes and its influence on colorectal cancer risk: based on 16S rDNA sequencing analysis.
    Eur J Gastroenterol Hepatol. 2024 Jul 15. doi: 10.1097/MEG.0000000000002827.
    >> Share

  27. DANIELSSON O, Vesterinen T, Arola J, Aberg F, et al
    Coexistence of metabolic-associated fatty liver disease and autoimmune or toxic liver disease.
    Eur J Gastroenterol Hepatol. 2024;36:961-969.
    >> Share

    June 2024
  28. POLPICHAI N, Saowapa S, Chan SY, Wattanachayakul P, et al
    Determining the association between systematic lupus erythematosus and the occurrence of primary biliary cirrhosis: a systematic review and meta-analysis.
    Eur J Gastroenterol Hepatol. 2024 Jun 19. doi: 10.1097/MEG.0000000000002791.
    >> Share

  29. OZTURK NB, Jamil LH
    An assessment of risk factors for recurrence and survival for patients undergoing liver resection for intrahepatic cholangiocarcinoma.
    Eur J Gastroenterol Hepatol. 2024;36:766-774.
    >> Share

    May 2024
  30. HUANG X, Chen W, Liu J, Liao Y, et al
    Clinicopathological features, prognostic factors, and prognostic survival prediction in patients with extrahepatic bile duct cancer liver metastasis.
    Eur J Gastroenterol Hepatol. 2024 May 31. doi: 10.1097/MEG.0000000000002799.
    >> Share

  31. CANCADO GGL, Gomes NMF, Couto CA, Cancado ELR, et al
    A new and simple score to predict adequate and deep response to ursodeoxycholic acid in patients with primary biliary cholangitis: the ALP-A score.
    Eur J Gastroenterol Hepatol. 2024;36:628-635.
    >> Share

    April 2024
  32. KIM NH, Kang JH, Kim HJ
    Association between nonalcoholic fatty liver disease and gallstone risk in nonobese and lean individuals.
    Eur J Gastroenterol Hepatol. 2024 Apr 17. doi: 10.1097/MEG.0000000000002779.
    >> Share

  33. LEE DU, Harmacinski A, Kolachana S, Bahadur A, et al
    The role of donor sex on the post-liver transplant outcomes in patients with primary sclerosing cholangitis.
    Eur J Gastroenterol Hepatol. 2024;36:452-468.
    >> Share

    February 2024
  34. LIANG X, Wang Z, Shu Q, Huang X, et al
    A bidirectional two-sample Mendelian randomization using the gut microbiota to reveal potential therapeutic targets for primary sclerosing cholangitis.
    Eur J Gastroenterol Hepatol. 2024;36:147-154.
    >> Share

    November 2023
  35. ZHANG W, Chen Z, Sa B
    Construction and validation of the predictive model for gallbladder cancer liver metastasis patients: a SEER-based study.
    Eur J Gastroenterol Hepatol. 2023 Nov 24. doi: 10.1097/MEG.0000000000002678.
    >> Share

    October 2023
  36. SUN N, Wang X, Wei J
    Gallstones, cholecystectomy and the risk of pancreatic cancer: an updated systematic review and meta-analysis of cohort studies.
    Eur J Gastroenterol Hepatol. 2023 Oct 6. doi: 10.1097/MEG.0000000000002652.
    >> Share

    September 2023
  37. JENSEN AH, Ytting H, Winther-Sorensen M, Burisch J, et al
    Autoimmune liver diseases and diabetes.
    Eur J Gastroenterol Hepatol. 2023;35:938-947.
    >> Share

    August 2023
  38. FORSTER K, Klein F, Simon N, Chhatwal P, et al
    Cultivation-based characterization of biliary microbiota in bile samples collected during routine endoscopic retrograde cholangiography: 10 years of experience at a tertiary center.
    Eur J Gastroenterol Hepatol. 2023 Aug 14. doi: 10.1097/MEG.0000000000002633.
    >> Share

  39. RIGAMONTI C, De Benedittis C, Labanca S, Vanni E, et al
    Excellent outcome in patients with primary biliary cholangitis in Northwest Italy followed up for up to 30 years.
    Eur J Gastroenterol Hepatol. 2023;35:899-906.
    >> Share

    June 2023
  40. HITAWALA AA, Almomani A, Onwuzo S, Boustany A, et al
    Prevalence of autoimmune, cholestatic and nonalcoholic fatty liver disease in celiac disease.
    Eur J Gastroenterol Hepatol. 2023 Jun 22. doi: 10.1097/MEG.0000000000002599.
    >> Share

  41. RIGAMONTI C, De Benedittis C, Labanca S, Vanni E, et al
    Excellent outcome in patients with primary biliary cholangitis in Northwest Italy followed up for up to 30 years.
    Eur J Gastroenterol Hepatol. 2023 Jun 6. doi: 10.1097/MEG.0000000000002582.
    >> Share

  42. TARAR ZI, Farooq U, Gandhi M, Ghous G, et al
    Effect of radiofrequency ablation in addition to biliary stent on overall survival and stent patency in malignant biliary obstruction: an updated systematic review and meta-analysis.
    Eur J Gastroenterol Hepatol. 2023;35:646-653.
    >> Share

    April 2023
  43. DIAS B, Aguiar A, Morais CI, Nery FG, et al
    Correlation between individual autoantibodies and clinical features in primary biliary cholangitis: results of a retrospective longitudinal study.
    Eur J Gastroenterol Hepatol. 2023 Apr 17. doi: 10.1097/MEG.0000000000002565.
    >> Share

  44. LI Z, Xu D, Yu H, Jiang H, et al
    Meta-analysis of the timing of laparoscopic cholecystectomy after endoscopic retrograde cholangiopancreatography in patients with cholecystolithiasis and choledocholithiasis.
    Eur J Gastroenterol Hepatol. 2023 Apr 11. doi: 10.1097/MEG.0000000000002553.
    >> Share

    February 2023
  45. KARAAHMET F, Kekilli M
    Endoscopic retrograde cholangiopancreatography-oriented surgery for accomplished treatment of Mirizzi syndrome: a single-center experience.
    Eur J Gastroenterol Hepatol. 2023 Feb 27:e002534.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016